CN Patent

CN104144678A — 含有抗病毒活性二氢喹唑啉衍生物的药物制剂

Assigned to Aicuris GmbH and Co KG · Expires 2014-11-12 · 12y expired

What this patent protects

本发明涉及药物制剂、尤其是用于静脉给药的药物制剂，其含有与选自环糊精、赖氨酸和精氨酸中的至少一种助剂组合的{8-氟-2-[4-(3-甲氧基苯基)哌嗪-1-基]-3-[2-甲氧基-5-(三氟甲基)苯基]-3,4-二氢喹唑啉-4-基}乙酸，涉及其生产方法，和涉及其治疗和/或预防疾病的用途，尤其是其作为抗病毒剂、优选地针对巨细胞病毒的用途。

USPTO Abstract

本发明涉及药物制剂、尤其是用于静脉给药的药物制剂，其含有与选自环糊精、赖氨酸和精氨酸中的至少一种助剂组合的{8-氟-2-[4-(3-甲氧基苯基)哌嗪-1-基]-3-[2-甲氧基-5-(三氟甲基)苯基]-3,4-二氢喹唑啉-4-基}乙酸，涉及其生产方法，和涉及其治疗和/或预防疾病的用途，尤其是其作为抗病毒剂、优选地针对巨细胞病毒的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN104144678A
Jurisdiction
CN
Classification
—
Expires
2014-11-12
Drug substance claim
No
Drug product claim
No
Assignee
Aicuris GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.